Loading viewer...
earnings
Format: PDF earnings
Ginkgo Bioworks' Q1 2024 business review covering operational updates, financial outlook, and strategic initiatives including site consolidation and workforce adjustments. The presentation details progress toward adjusted EBITDA breakeven, Biofab1 opening timeline, and expansion of biodefense capabilities through the bioradar network and AI tools development.
earnings
56 Pages
Sibanye Stillwater Limited
Qantas Airways FY21 Results Presentation 2021
earningsearnings
37 Pages
Qantas Airways Limited
Universal Technical Institute Q2 2024 Financial Results
earningsearnings
22 Pages
Universal Technical Institute, Inc.